Ocean Biomedical Competitors and Similar CompaniesClear all
Ocean Biomedical's competitors and similar companies include Cullgen, Paradigm Diagnostics and Divide & Conquer.
 Ocean Biomedical Ocean Biomedical (formerly known as Aesther Healthcare Acquisition) is a biopharmaceutical company that focuses on medical research in oncology, fibrosis, infectious disease, and inflammation. |  Cullgen Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders. |  Paradigm Diagnostics Paradigm Diagnostics is a precision medicine company focused on comprehensive cancer testing. |  Divide & Conquer Divide & Conquer is focused on developing new therapeutics against glioblastoma (grade IV astrocytoma), a particularly lethal form of brain cancer, and other solid tumors with very poor life expectancy. | |
Founding Date | Founding Date 2019 | Founding Date 2018 | Founding Date 2012 | Founding Date 2018 |
Type | Type Public | Type Private | Type Private | Type Private |
Tags | ||||
Locations | Locations Providence, US HQ | Locations San Diego, US HQ Shanghai, CN Tokyo, JP | Locations Phoenix, US HQ | Locations Babraham, GB HQ |
Employees | Employees 9 | Employees 4 | Employees 717% increase | Employees 2 |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 16m (about 7 years ago) | Latest funding round $ 15m (almost 7 years ago) | Latest funding round $ 12.5m (over 6 years ago) |
Total funding raised | Total funding raised $ 1m | Total funding raised $ 31m | Total funding raised $ 23.9m | Total funding raised $ 12.5m |
For sources of this data, please see the company profile
View Company Profiles
Cullgen
HQ
San Diego, US
Employees
4
Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders.
View companyParadigm Diagnostics
HQ
Phoenix, US
Employees
7↑ 17% increase
Paradigm Diagnostics is a precision medicine company focused on comprehensive cancer testing.
View companyDivide & Conquer
HQ
Babraham, GB
Employees
2
Divide & Conquer is focused on developing new therapeutics against glioblastoma (grade IV astrocytoma), a particularly lethal form of brain cancer, and other solid tumors with very poor life expectancy.
View company